Nanalysis Scientific Corp. (NSCIF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 8 | 16 | 25 | 28 | 45 | 40 | 40 | 42 |
| Operating profit | CAD m | -4 | -2 | ||||||
| Net profit | CAD m | -4 | -2 | -10 | -17 | -14 | -6 | -4 | -1 |
| EPS reported | CAD | -0.05 | -0.03 | ||||||
| Operating cashflow per share | CAD | 0.03 | 0.00 | ||||||
| Capex per share | CAD | 0.02 | 0.01 | ||||||
| FCF per share | CAD | 0.01 | -0.01 | ||||||
| Free cash flow | CAD m | 2 | 2 | ||||||
| Net debt | CAD m | 15 | 13 | ||||||
| Book value equity | CAD m | 13 | 12 | ||||||
| Book value per share | CAD | 0.12 | 0.09 | ||||||
| Number of shares | m | 114.71 | 138.52 | ||||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.31 | 1.43 | ||||||
| P/S LTM | x | 0.44 | 0.44 | ||||||
| P/FCF LTM | x | 11.23 | 9.95 | ||||||
| EV/EBITDA LTM | x | -41.00 | 67.23 | ||||||
| EV/Sales LTM | x | 0.86 | 0.72 | ||||||
| Earnings Yield LTM | % | -32.13% | -32.35% | ||||||
| FCF Yield | % | +8.90% | +10.05% | ||||||
| Quality | |||||||||
| ROE | % | -42.16% | -44.82% | ||||||
| ROIC | % | -11.85% | -12.52% | ||||||
| Operating margin | % | -9.38% | -8.89% | ||||||
| Gross margin | % | +24.83% | +21.89% | ||||||
| FCF/Sales | % | +3.91% | -2.14% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -11.79% | -11.24% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +11.60% | +26.01% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.09 | 0.13 | ||||||
| Net Debt/EBITDA | x | -20.16 | -16.24 | ||||||
| EBIT/Net interest | x | -2.75 | -2.52 | ||||||
| Net debt/market cap | % | +90.79% | +92.28% | ||||||
| Net debt/Equity | x | 1.15 | 1.09 | ||||||
| Gross debt/equity | x | 1.31 | 1.13 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Nanalysis Scientific Corp. (NSCIF)
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free